Softcell is a medical device company that has invented a revolutionary pH monitoring system, currently being developed to address the un-met clinical need for real time cellular pH monitoring.
Softcell’s patented technology can be applied to any soft tissue, to measure pH in circumstances where trauma or acute illness could be causing adverse effects. The pH monitoring system which comprises a monitor with single or multiple probes is currently undergoing development and approvals to convert the technology to a commercial system.
A user friendly, handheld, portable unit capable of real time monitoring of tissue pH, recording up to four channels simultaneously. The pH Monitor will have a colour graphical display to show multiple channel readings and trend graphs. The pH Monitor will be equipped with audible and visual alarms to alert the clinician to intervene in a timely manner.Â
Trauma and other conditions can give rise to a serious complication called Acute Compartment Syndrome (ACS) that gradually cuts off the blood supply to the affected limb(s).Â
Trauma related ACS can be detected by measuring pressure and by clinical assessment. However, both pressure monitoring and clinical assessment are inaccurate diagnostic methods that can delay treatment, which may result in devastating disabilities, amputation or death. By comparison, pH monitoring can provide the earliest indication of potential tissue damage, allowing timely intervention to minimise the possible adverse outcomes.
All 7 full clinical studies were highly significant in that pH accurately identified the clinical problems with ease, within each of the clinical fields.
Contact us for more information on the research.
Trauma & Orthopaedics:
3 Full Studies & 1 Pilot
(143 patients)
Vascular Surgery:
2 Full Studies & 2 Pilots
(94 patients)
Sports Medicine:
2 Full Studies
(40 healthy volunteers)
Intensive Care Medicine:
Pilot study
(8 patients)
Get in touch